Full Transcript Opening Hook and Guest Introduction 0:02 What if healthcare [music] waste is not 0:02 What if healthcare [music] waste is not coming from bad medicine, but from 0:04 coming from bad medicine, but from 0:04 coming from bad medicine, but from delayed decisions? Every extra [music] 0:07 delayed decisions? Every extra [music] 0:07 delayed decisions? Every extra [music] handoff, prior authorization, and 0:09 handoff, prior authorization, and 0:09 handoff, prior authorization, and disconnected workflow can slow patients 0:12 disconnected workflow can slow patients 0:12 disconnected workflow can slow patients from [music] getting the right 0:14 from [music] getting the right 0:14 from [music] getting the right treatment. Today, Dr. Julie Schulz, 0:16 treatment. Today, Dr. Julie Schulz, 0:17 treatment. Today, Dr. Julie Schulz, physician executive and VP of product 0:19 physician executive and VP of product 0:19 physician executive and VP of product [music] at Avalon Healthcare Solutions, 0:22 [music] at Avalon Healthcare Solutions, 0:22 [music] at Avalon Healthcare Solutions, breaks down how diagnostics, payer 0:25 breaks down how diagnostics, payer 0:25 breaks down how diagnostics, payer partnerships, [music] 0:26 partnerships, [music] 0:26 partnerships, [music] and smarter workflow design are helping 0:29 and smarter workflow design are helping 0:29 and smarter workflow design are helping speed care, reduce [music] waste, and 0:31 speed care, reduce [music] waste, and 0:31 speed care, reduce [music] waste, and make precision medicine actually 0:34 make precision medicine actually 0:34 make precision medicine actually actionable at scale. 0:37 actionable at scale. 0:37 actionable at scale. Healthcare entrepreneurs, are you ready 0:39 Healthcare entrepreneurs, are you ready 0:39 Healthcare entrepreneurs, are you ready [music] to rewrite the rules for your 0:41 [music] to rewrite the rules for your 0:41 [music] to rewrite the rules for your business so you can have more time off, 0:43 business so you can have more time off, 0:43 business so you can have more time off, a great [music] team, and more income 0:45 a great [music] team, and more income 0:45 a great [music] team, and more income while creating a positive social impact? 0:48 while creating a positive social impact? 0:48 while creating a positive social impact? Then, you are in the right place. 0:51 Then, you are in the right place. 0:51 Then, you are in the right place. [music] Welcome to The Provider's Edge. 0:53 [music] Welcome to The Provider's Edge. 0:54 [music] Welcome to The Provider's Edge. I'm your host, Sabrina Runbeck. I'm a 0:56 I'm your host, Sabrina Runbeck. I'm a 0:56 I'm your host, Sabrina Runbeck. I'm a provider, an international [music] peak 0:58 provider, an international [music] peak 0:58 provider, an international [music] peak performance keynote speaker, and a 0:59 performance keynote speaker, and a 0:59 performance keynote speaker, and a best-selling author. Let's open the 1:01 best-selling author. Let's open the 1:01 best-selling author. Let's open the gateway to profitability for you today. 1:04 gateway to profitability for you today. 1:04 gateway to profitability for you today. [music] 1:04 [music] 1:04 [music] My guest and I help healthcare 1:07 My guest and I help healthcare 1:07 My guest and I help healthcare entrepreneurs and startup founders like 1:09 entrepreneurs and startup founders like 1:09 entrepreneurs and startup founders like you break through barriers so you can 1:12 you break through barriers so you can 1:12 you break through barriers so you can control your business, control your 1:13 control your business, control your 1:13 control your business, control your life, and control [music] your future. 1:16 life, and control [music] your future. 1:16 life, and control [music] your future. This is your defining moment to be a 1:18 This is your defining moment to be a 1:18 This is your defining moment to be a disruptor in healthcare. 1:25 Hi everyone. We are back at Health. It's 1:26 Hi everyone. We are back at Health. It's always exciting to be in the room full 1:28 always exciting to be in the room full 1:28 always exciting to be in the room full of thousands of people who are care 1:29 of thousands of people who are care 1:30 of thousands of people who are care about innovation, care about pushing the 1:31 about innovation, care about pushing the 1:31 about innovation, care about pushing the boundaries of what we can do in 1:33 boundaries of what we can do in 1:33 boundaries of what we can do in healthcare. And today, we have Dr. Julie 1:35 healthcare. And today, we have Dr. Julie 1:36 healthcare. And today, we have Dr. Julie Schulz here with us for Avalon. So, 1:39 Schulz here with us for Avalon. So, 1:39 Schulz here with us for Avalon. So, Julie, what truly brought you here this 1:41 Julie, what truly brought you here this 1:41 Julie, what truly brought you here this time? Every year's a little bit 1:42 time? Every year's a little bit 1:42 time? Every year's a little bit different. We're popping up with new
Avalonu2019s Diagnostics and Workflow Strategy 1:44 different. We're popping up with new 1:44 different. We're popping up with new innovation, new pavilions. What's 1:46 innovation, new pavilions. What's 1:47 innovation, new pavilions. What's exciting for you this year? So, we know 1:49 exciting for you this year? So, we know 1:49 exciting for you this year? So, we know every day there's 10 new genetic tests 1:51 every day there's 10 new genetic tests 1:51 every day there's 10 new genetic tests that are they get approved. And the 1:52 that are they get approved. And the 1:52 that are they get approved. And the number of tests, whether they're routine 1:54 number of tests, whether they're routine 1:54 number of tests, whether they're routine genetic precision medicine, is just 1:56 genetic precision medicine, is just 1:56 genetic precision medicine, is just skyrocketing. And what are clinicians to 1:58 skyrocketing. And what are clinicians to 1:58 skyrocketing. And what are clinicians to do, right? How are they ever going to 2:00 do, right? How are they ever going to 2:00 do, right? How are they ever going to keep up with all of this information 2:01 keep up with all of this information 2:01 keep up with all of this information with guidelines that change every 3 2:03 with guidelines that change every 3 2:03 with guidelines that change every 3 months? So, at Avalon, we're a lab 2:05 months? So, at Avalon, we're a lab 2:05 months? So, at Avalon, we're a lab benefits management and insights 2:07 benefits management and insights 2:07 benefits management and insights company, and we're we're helping to kind 2:09 company, and we're we're helping to kind 2:09 company, and we're we're helping to kind of help providers, payers make sense of 2:11 of help providers, payers make sense of 2:11 of help providers, payers make sense of all of that in a very evidence-based, 2:13 all of that in a very evidence-based, 2:13 all of that in a very evidence-based, data-driven way. Awesome. And I think 2:16 data-driven way. Awesome. And I think 2:16 data-driven way. Awesome. And I think for us in healthcare, mostly people are 2:18 for us in healthcare, mostly people are 2:18 for us in healthcare, mostly people are like, "Show me your data." Right? And 2:20 like, "Show me your data." Right? And 2:20 like, "Show me your data." Right? And then I think we're so ingrained into how 2:22 then I think we're so ingrained into how 2:22 then I think we're so ingrained into how do we present data, understand data, you 2:24 do we present data, understand data, you 2:24 do we present data, understand data, you kind of have all the innovation out 2:26 kind of have all the innovation out 2:26 kind of have all the innovation out there solving a big problem. Is that 2:29 there solving a big problem. Is that 2:29 there solving a big problem. Is that actually getting the engagement that we 2:31 actually getting the engagement that we 2:31 actually getting the engagement that we want? Right? Because we can build all 2:33 want? Right? Because we can build all 2:33 want? Right? Because we can build all these technology solutions, but if 2:35 these technology solutions, but if 2:35 these technology solutions, but if people are not using it, right? If we're 2:37 people are not using it, right? If we're 2:37 people are not using it, right? If we're not using it, clinician, patient's not 2:39 not using it, clinician, patient's not 2:39 not using it, clinician, patient's not using it, then what's the point of 2:40 using it, then what's the point of 2:40 using it, then what's the point of throwing millions dollars in it, right? 2:42 throwing millions dollars in it, right? 2:42 throwing millions dollars in it, right? So, with you guys with the 2:44 So, with you guys with the 2:44 So, with you guys with the testing and then focus on this data 2:46 testing and then focus on this data 2:46 testing and then focus on this data part, how do you see the adoption 2:48 part, how do you see the adoption 2:48 part, how do you see the adoption usability come to play? The data, you're 2:51 usability come to play? The data, you're 2:51 usability come to play? The data, you're right. The data is just one small part 2:53 right. The data is just one small part 2:53 right. The data is just one small part of it, all right? Now, first of all, we 2:54 of it, all right? Now, first of all, we 2:54 of it, all right? Now, first of all, we have to have clinicians, data 2:56 have to have clinicians, data 2:56 have to have clinicians, data scientists, all the right people at the 2:58 scientists, all the right people at the 2:58 scientists, all the right people at the table to first of all, do design the 3:00 table to first of all, do design the 3:00 table to first of all, do design the models and make sense of it in a way 3:02 models and make sense of it in a way 3:02 models and make sense of it in a way that makes sense with good clinical 3:04 that makes sense with good clinical 3:04 that makes sense with good clinical medicine. But then thinking about how do 3:06 medicine. But then thinking about how do 3:06 medicine. But then thinking about how do we make it actionable for providers? How 3:08 we make it actionable for providers? How 3:08 we make it actionable for providers? How do we engage payers? How are we working 3:10 do we engage payers? How are we working 3:11 do we engage payers? How are we working with nurses, mid-level providers? It's 3:13 with nurses, mid-level providers? It's 3:13 with nurses, mid-level providers? It's often times it's the physician's kind of 3:15 often times it's the physician's kind of 3:15 often times it's the physician's kind of that last point of care. So, we think 3:17 that last point of care. So, we think 3:17 that last point of care. So, we think about and I as a VP of product, I think 3:19 about and I as a VP of product, I think 3:19 about and I as a VP of product, I think a lot about that workflow of how it all 3:21 a lot about that workflow of how it all 3:21 a lot about that workflow of how it all comes together in terms of making sure 3:24 comes together in terms of making sure 3:24 comes together in terms of making sure that the workflow is thinking about all 3:26 that the workflow is thinking about all 3:26 that the workflow is thinking about all of those steps, where things get lost, 3:28 of those steps, where things get lost, 3:28 of those steps, where things get lost, and how we can make sure that at the end 3:30 and how we can make sure that at the end 3:30 and how we can make sure that at the end of the day, all the work we've done 3:32 of the day, all the work we've done 3:32 of the day, all the work we've done actually gets used. Yeah, exactly. 3:34 actually gets used. Yeah, exactly. 3:34 actually gets used. Yeah, exactly. Because it's hard work, right? Building 3:35 Because it's hard work, right? Building 3:35 Because it's hard work, right? Building any business is not easy. And 3:37 any business is not easy. And 3:38 any business is not easy. And innovation, we have so many regulations, 3:40 innovation, we have so many regulations, 3:40 innovation, we have so many regulations, layer of people that need to get 3:42 layer of people that need to get 3:42 layer of people that need to get involved, approved. So, it's really 3:44 involved, approved. So, it's really 3:44 involved, approved. So, it's really crucial to say, "What does that entire 3:46 crucial to say, "What does that entire 3:46 crucial to say, "What does that entire journey looks like? Who's all have their 3:49 journey looks like? Who's all have their 3:49 journey looks like? Who's all have their hands in this process?" And making sure 3:51 hands in this process?" And making sure 3:51 hands in this process?" And making sure that we feel good about the impact that 3:54 that we feel good about the impact that 3:54 that we feel good about the impact that can be created. And it seems to be easy 3:57 can be created. And it seems to be easy 3:57 can be created. And it seems to be easy getting to the point of what the result 4:00 getting to the point of what the result 4:00 getting to the point of what the result can be. And I think it sometimes it's 4:02 can be. And I think it sometimes it's 4:02 can be. And I think it sometimes it's also about like making it so simple that 4:06 also about like making it so simple that 4:06 also about like making it so simple that people can talk about it so much easier, 4:07 people can talk about it so much easier, 4:07 people can talk about it so much easier, right? Also because genetic testing, I 4:10 right? Also because genetic testing, I 4:10 right? Also because genetic testing, I think people understand the importance 4:12 think people understand the importance 4:12 think people understand the importance of it, but the application can be so 4:14 of it, but the application can be so 4:14 of it, but the application can be so wide. And then from the lineage testing 4:18 wide. And then from the lineage testing 4:18 wide. And then from the lineage testing when 20 4:19 when 20 4:20 when 20 they started to now people can do 4:22 they started to now people can do 4:22 they started to now people can do genetic testing to match the dose of 4:25 genetic testing to match the dose of 4:25 genetic testing to match the dose of medication, right? And then supplements. 4:27 medication, right? And then supplements. 4:27 medication, right? And then supplements. What are you actually missing? You're 4:29 What are you actually missing? You're 4:29 What are you actually missing? You're not just putting everything in your body 4:31 not just putting everything in your body 4:31 not just putting everything in your body and don't really know what's the marker 4:32 and don't really know what's the marker 4:32 and don't really know what's the marker for that, right? So, all of this. So, is 4:35 for that, right? So, all of this. So, is 4:35 for that, right? So, all of this. So, is there anything specific you guys are 4:37 there anything specific you guys are 4:37 there anything specific you guys are focusing on any specific disease process 4:40 focusing on any specific disease process 4:40 focusing on any specific disease process or any application in terms of we see 4:43 or any application in terms of we see 4:43 or any application in terms of we see that more of a direct-to-consumer or is 4:45 that more of a direct-to-consumer or is 4:45 that more of a direct-to-consumer or is more of a clinician led in smaller 4:47 more of a clinician led in smaller 4:47 more of a clinician led in smaller practice versus a a system wide? Let me 4:50 practice versus a a system wide? Let me 4:50 practice versus a a system wide? Let me walk you through an example in oncology. 4:51 walk you through an example in oncology. 4:51 walk you through an example in oncology. So, again, you know, it's impossible for 4:53 So, again, you know, it's impossible for 4:53 So, again, you know, it's impossible for physicians providers to keep up with all 4:55 physicians providers to keep up with all 4:55 physicians providers to keep up with all of the guidelines, all of the evidence. 4:57 of the guidelines, all of the evidence. 4:57 of the guidelines, all of the evidence. We're working right now in non-small 4:59 We're working right now in non-small 4:59 We're working right now in non-small cell lung cancer, which is one of the 5:00 cell lung cancer, which is one of the 5:00 cell lung cancer, which is one of the few tumor types where there's an 5:02 few tumor types where there's an 5:02 few tumor types where there's an approved liquid biopsy that helps 5:04 approved liquid biopsy that helps 5:04 approved liquid biopsy that helps actually pick which treatment is going 5:06 actually pick which treatment is going 5:06 actually pick which treatment is going to be effective and matches the mutation 5:08 to be effective and matches the mutation 5:08 to be effective and matches the mutation to the drug. But again, it's all so new. 5:11 to the drug. But again, it's all so new. 5:11 to the drug. But again, it's all so new. Physicians are treating many different 5:12 Physicians are treating many different 5:12 Physicians are treating many different tumor types. We see that only 18% of 5:15 tumor types. We see that only 18% of 5:15 tumor types. We see that only 18% of patients are actually having this test 5:16 patients are actually having this test 5:16 patients are actually having this test ordered even though it's in the 5:17 ordered even though it's in the 5:17 ordered even though it's in the guidelines. And then when they actually 5:20 guidelines. And then when they actually 5:20 guidelines. And then when they actually get the results, only 44% of patients 5:23 get the results, only 44% of patients 5:23 get the results, only 44% of patients are actually on the drug that was 5:24 are actually on the drug that was 5:24 are actually on the drug that was recommended. So, not only from a 5:26 recommended. So, not only from a 5:26 recommended. So, not only from a financial, but also a clinical 5:28 financial, but also a clinical 5:28 financial, but also a clinical standpoint, that's just a huge 5:30 standpoint, that's just a huge 5:30 standpoint, that's just a huge opportunity to help them out. So, here's 5:32 opportunity to help them out. So, here's 5:32 opportunity to help them out. So, here's what we're doing. We're working with the 5:33 what we're doing. We're working with the 5:33 what we're doing. We're working with the payers, and we're also trying to ease 5:35 payers, and we're also trying to ease 5:35 payers, and we're also trying to ease that prior authorization process so that
Oncology Use Case and Payer Adoption 5:38 that prior authorization process so that 5:38 that prior authorization process so that there's that administrative burden, that 5:40 there's that administrative burden, that 5:40 there's that administrative burden, that headache that I think is part of why 5:42 headache that I think is part of why 5:42 headache that I think is part of why physicians aren't ordering the test or 5:43 physicians aren't ordering the test or 5:43 physicians aren't ordering the test or aren't following the care pathways we 5:45 aren't following the care pathways we 5:45 aren't following the care pathways we know they should. We're trying to make 5:46 know they should. We're trying to make 5:46 know they should. We're trying to make that as easy as possible. And so, what 5:48 that as easy as possible. And so, what 5:48 that as easy as possible. And so, what we've found is not only by providing 5:50 we've found is not only by providing 5:50 we've found is not only by providing that decision support, but again, easing 5:52 that decision support, but again, easing 5:52 that decision support, but again, easing that administrative burden makes it 5:54 that administrative burden makes it 5:54 that administrative burden makes it easier for them just to do the right 5:55 easier for them just to do the right 5:56 easier for them just to do the right thing the first time. They don't have to 5:57 thing the first time. They don't have to 5:57 thing the first time. They don't have to second-guess it. And then, we're able to 5:58 second-guess it. And then, we're able to 5:58 second-guess it. And then, we're able to bring the time from taking the test to 6:01 bring the time from taking the test to 6:01 bring the time from taking the test to getting the drug from 60 days down to 6:03 getting the drug from 60 days down to 6:03 getting the drug from 60 days down to 15. So, I think it's a nice kind of 6:05 15. So, I think it's a nice kind of 6:05 15. So, I think it's a nice kind of tangible way that it brings together, 6:07 tangible way that it brings together, 6:07 tangible way that it brings together, again, like with all of the right 6:09 again, like with all of the right 6:09 again, like with all of the right stakeholders at the table, including the 6:10 stakeholders at the table, including the 6:10 stakeholders at the table, including the payers, and and really helping patients 6:12 payers, and and really helping patients 6:12 payers, and and really helping patients get the best possible care. Yeah, I see 6:15 get the best possible care. Yeah, I see 6:15 get the best possible care. Yeah, I see it's all about like everything we're 6:16 it's all about like everything we're 6:16 it's all about like everything we're looking at is like faster to treatment, 6:18 looking at is like faster to treatment, 6:18 looking at is like faster to treatment, right? Or can we prevent something from 6:21 right? Or can we prevent something from 6:21 right? Or can we prevent something from progressing to the end stage? So, for 6:23 progressing to the end stage? So, for 6:23 progressing to the end stage? So, for you guys, it's really shorten that gap 6:25 you guys, it's really shorten that gap 6:25 you guys, it's really shorten that gap of delaying treatment because that's the 6:28 of delaying treatment because that's the 6:28 of delaying treatment because that's the standard is the standard, and then we 6:30 standard is the standard, and then we 6:30 standard is the standard, and then we didn't have any option until now. And 6:32 didn't have any option until now. And 6:32 didn't have any option until now. And it's the exciting thing to go after the 6:35 it's the exciting thing to go after the 6:35 it's the exciting thing to go after the payers because they're already being 6:37 payers because they're already being 6:37 payers because they're already being identifying triggering with the disease 6:41 identifying triggering with the disease 6:41 identifying triggering with the disease coding and then things. So, we actually 6:43 coding and then things. So, we actually 6:43 coding and then things. So, we actually can help narrow down the group. And so, 6:46 can help narrow down the group. And so, 6:46 can help narrow down the group. And so, how many payer groups have you guys 6:48 how many payer groups have you guys 6:48 how many payer groups have you guys already been engaged with? 6:49 already been engaged with? 6:49 already been engaged with? >> So, we're working with over 30 payers. 6:51 >> So, we're working with over 30 payers. 6:51 >> So, we're working with over 30 payers. We actually have we're now contracting 6:52 We actually have we're now contracting 6:53 We actually have we're now contracting for 90 million lives. So, one in four.
Scaling Through Payers and Employers 6:56 for 90 million lives. So, one in four. 6:56 for 90 million lives. So, one in four. So, yeah, we're working with a a very 6:57 So, yeah, we're working with a a very 6:57 So, yeah, we're working with a a very broad swath of the the US. And lab 7:00 broad swath of the the US. And lab 7:00 broad swath of the the US. And lab spending is it's overlooked. It's less 7:01 spending is it's overlooked. It's less 7:01 spending is it's overlooked. It's less than 5% of overall spend, but it has 7:04 than 5% of overall spend, but it has 7:04 than 5% of overall spend, but it has outsized influence. We know that 70% of 7:07 outsized influence. We know that 70% of 7:07 outsized influence. We know that 70% of clinical decisions take into account 7:09 clinical decisions take into account 7:09 clinical decisions take into account some type of testing, and we know that 7:11 some type of testing, and we know that 7:11 some type of testing, and we know that 50% of visits incorporate some type of a 7:13 50% of visits incorporate some type of a 7:13 50% of visits incorporate some type of a lab. And so, even though it's a small 7:15 lab. And so, even though it's a small 7:15 lab. And so, even though it's a small part of spending, it affects so many 7:17 part of spending, it affects so many 7:17 part of spending, it affects so many downstream things. And so, making sure 7:19 downstream things. And so, making sure 7:19 downstream things. And so, making sure that, again, all the players at the 7:20 that, again, all the players at the 7:20 that, again, all the players at the table have the information that they 7:22 table have the information that they 7:22 table have the information that they need in the right form, in a way that's 7:24 need in the right form, in a way that's 7:24 need in the right form, in a way that's actionable, is really powerful. Yeah. I 7:27 actionable, is really powerful. Yeah. I 7:27 actionable, is really powerful. Yeah. I see you guys are seeing to next year, 7:29 see you guys are seeing to next year, 7:29 see you guys are seeing to next year, right? We're going to the last quarter 7:31 right? We're going to the last quarter 7:31 right? We're going to the last quarter and going to the next year. What's the 7:33 and going to the next year. What's the 7:33 and going to the next year. What's the bigger picture for next year that you 7:35 bigger picture for next year that you 7:35 bigger picture for next year that you hoping to achieve? Oh gosh, you know, 7:37 hoping to achieve? Oh gosh, you know, 7:37 hoping to achieve? Oh gosh, you know, I'm going to be overly optimistic as I 7:39 I'm going to be overly optimistic as I 7:39 I'm going to be overly optimistic as I am, but it's It's a rough year for 7:40 am, but it's It's a rough year for 7:40 am, but it's It's a rough year for payers, right? Healthcare expenditures 7:42 payers, right? Healthcare expenditures 7:42 payers, right? Healthcare expenditures have, you know, exceeded I think even 7:44 have, you know, exceeded I think even 7:44 have, you know, exceeded I think even what most people were expecting, and 7:46 what most people were expecting, and 7:46 what most people were expecting, and everyone's looking for, you know, ways 7:47 everyone's looking for, you know, ways 7:47 everyone's looking for, you know, ways to save money now. Fortunately, we have 7:50 to save money now. Fortunately, we have 7:50 to save money now. Fortunately, we have one of our solutions does that and it 7:51 one of our solutions does that and it 7:51 one of our solutions does that and it really helps to make sure that payers 7:53 really helps to make sure that payers 7:53 really helps to make sure that payers are only spending money on the most 7:54 are only spending money on the most 7:54 are only spending money on the most evidence-based, clinically backed tests, 7:57 evidence-based, clinically backed tests, 7:57 evidence-based, clinically backed tests, and we can help them save money 7:58 and we can help them save money 7:58 and we can help them save money tomorrow. But my hope is that we start 8:00 tomorrow. But my hope is that we start 8:00 tomorrow. But my hope is that we start thinking even longer term. So, while 8:01 thinking even longer term. So, while 8:01 thinking even longer term. So, while we're doing that, how we can start 8:03 we're doing that, how we can start 8:03 we're doing that, how we can start making sure that we diagnosed our our 8:05 making sure that we diagnosed our our 8:05 making sure that we diagnosed our our chronic disease patients who maybe 8:07 chronic disease patients who maybe 8:07 chronic disease patients who maybe aren't getting the care that they need. 8:09 aren't getting the care that they need. 8:09 aren't getting the care that they need. How can we use analytics to make sure 8:10 How can we use analytics to make sure 8:11 How can we use analytics to make sure that our precious GLP-1 dollar that 8:13 that our precious GLP-1 dollar that 8:13 that our precious GLP-1 dollar that we're spending is going to the patients 8:15 we're spending is going to the patients 8:15 we're spending is going to the patients who need it the most? We see that in our 8:17 who need it the most? We see that in our 8:17 who need it the most? We see that in our data that, unfortunately, among 8:19 data that, unfortunately, among 8:19 data that, unfortunately, among diabetics, the healthier patients are 8:20 diabetics, the healthier patients are 8:20 diabetics, the healthier patients are three times more likely to get a GLP-1 8:22 three times more likely to get a GLP-1 8:22 three times more likely to get a GLP-1 prescription, and among obese patients, 8:25 prescription, and among obese patients, 8:25 prescription, and among obese patients, the healthier ones are 14 times more 8:27 the healthier ones are 14 times more 8:27 the healthier ones are 14 times more likely to get a GLP-1 prescription. So, 8:29 likely to get a GLP-1 prescription. So, 8:29 likely to get a GLP-1 prescription. So, I really hope that we start looking at a 8:31 I really hope that we start looking at a 8:31 I really hope that we start looking at a longer-term view and finding ways that 8:34 longer-term view and finding ways that 8:34 longer-term view and finding ways that we can really, you know, get that 8:35 we can really, you know, get that 8:35 we can really, you know, get that preventive care in the hands of patients 8:37 preventive care in the hands of patients 8:37 preventive care in the hands of patients and providers sooner. 8:40 and providers sooner. 8:40 >> [music] >> What you just heard is a reminder that 8:42 >> What you just heard is a reminder that 8:42 >> What you just heard is a reminder that having great data is not enough. If 8:45 having great data is not enough. If 8:45 having great data is not enough. If clinicians, [music] payers, and care 8:47 clinicians, [music] payers, and care 8:47 clinicians, [music] payers, and care teams can't use it easily, the value 8:50 teams can't use it easily, the value 8:50 teams can't use it easily, the value gets stuck. Dr. Julie also showed us 8:53 gets stuck. Dr. Julie also showed us 8:53 gets stuck. Dr. Julie also showed us something founders [music] 8:54 something founders [music] 8:54 something founders [music] should pay attention to, such as when 8:57 should pay attention to, such as when 8:57 should pay attention to, such as when you remove friction, like prior 8:59 you remove friction, like prior 9:00 you remove friction, like prior authorization delays and [music] 9:01 authorization delays and [music] 9:01 authorization delays and [music] confusing workflow, outcomes move 9:04 confusing workflow, outcomes move 9:04 confusing workflow, outcomes move faster. Innovation wins when it [music] 9:07 faster. Innovation wins when it [music] 9:07 faster. Innovation wins when it [music] fits in real life, not just when it 9:09 fits in real life, not just when it 9:10 fits in real life, not just when it looks good on paper. Before we jump into 9:12 looks good on paper. Before we jump into 9:12 looks good on paper. Before we jump into the second half of today's [music] 9:15 the second half of today's [music] 9:15 the second half of today's [music] conversation, let's take a pause and 9:18 conversation, let's take a pause and 9:18 conversation, let's take a pause and share with something that might be 9:20 share with something that might be 9:20 share with something that might be useful for many of you listening. 9:22 useful for many of you listening. 9:22 useful for many of you listening. >> [music] 9:22 >> [music] 9:22 >> [music] >> If you are a founder with the
Long-Term Incentives and Care Coordination 9:24 >> If you are a founder with the 9:24 >> If you are a founder with the established solution beyond series A, 9:27 established solution beyond series A, 9:27 established solution beyond series A, [music] 9:27 [music] 9:27 [music] or if you have been leading a 9:31 or if you have been leading a 9:31 or if you have been leading a established [music] organization, 9:34 established [music] organization, 9:34 established [music] organization, whether that's a health system, ACO, 9:37 whether that's a health system, ACO, 9:37 whether that's a health system, ACO, [music] multiple clinical groups, we 9:40 [music] multiple clinical groups, we 9:40 [music] multiple clinical groups, we would love to hear from you because 9:42 would love to hear from you because 9:42 would love to hear from you because [music] we know how you build your 9:45 [music] we know how you build your 9:45 [music] we know how you build your organization, how you're leading, how 9:47 organization, how you're leading, how 9:47 organization, how you're leading, how you're creating impact matters [music] 9:49 you're creating impact matters [music] 9:49 you're creating impact matters [music] that everyone can learn from. That go to 9:51 that everyone can learn from. That go to 9:51 that everyone can learn from. That go to theprovidersedge.com 9:54 theprovidersedge.com 9:54 theprovidersedge.com to apply to be our next speaker. [music] 9:57 to apply to be our next speaker. [music] 9:57 to apply to be our next speaker. [music] Right. It's all about like finding the 9:59 Right. It's all about like finding the 9:59 Right. It's all about like finding the right people instead of just thinking, 10:00 right people instead of just thinking, 10:00 right people instead of just thinking, "Oh, this sounds good. This is good. Let 10:02 "Oh, this sounds good. This is good. Let 10:02 "Oh, this sounds good. This is good. Let me just grab a prescription and start 10:04 me just grab a prescription and start 10:04 me just grab a prescription and start testing it, right?" And then 10:06 testing it, right?" And then 10:06 testing it, right?" And then when those are really not at their 10:08 when those are really not at their 10:08 when those are really not at their space, even though they think it is part 10:11 space, even though they think it is part 10:11 space, even though they think it is part of their treatment plan. And then 10:13 of their treatment plan. And then 10:13 of their treatment plan. And then sometimes because some of these things 10:15 sometimes because some of these things 10:15 sometimes because some of these things are too readily available and not 10:18 are too readily available and not 10:18 are too readily available and not regulated enough, and that's why we're 10:20 regulated enough, and that's why we're 10:20 regulated enough, and that's why we're seeing that skew of, "Oh, everyone's on 10:22 seeing that skew of, "Oh, everyone's on 10:22 seeing that skew of, "Oh, everyone's on it." Right? And like everyone somehow 10:24 it." Right? And like everyone somehow 10:24 it." Right? And like everyone somehow just able to get it, but not having that 10:26 just able to get it, but not having that 10:26 just able to get it, but not having that holistic view of how medicine should be 10:28 holistic view of how medicine should be 10:29 holistic view of how medicine should be and taking into all the consideration of 10:31 and taking into all the consideration of 10:31 and taking into all the consideration of the family, their genetics, and their 10:34 the family, their genetics, and their 10:34 the family, their genetics, and their other comorbidities Yeah. When making 10:36 other comorbidities Yeah. When making 10:36 other comorbidities Yeah. When making those decisions. So, we're excited for 10:39 those decisions. So, we're excited for 10:39 those decisions. So, we're excited for you guys to be on this journey. I also 10:41 you guys to be on this journey. I also 10:41 you guys to be on this journey. I also always love to ask a fun question. If we 10:44 always love to ask a fun question. If we 10:44 always love to ask a fun question. If we give you a magic wand, the magic wand 10:46 give you a magic wand, the magic wand 10:46 give you a magic wand, the magic wand grants you three wishes to help speed up 10:49 grants you three wishes to help speed up 10:49 grants you three wishes to help speed up the goal for the next year, how would 10:51 the goal for the next year, how would 10:51 the goal for the next year, how would you use the magic wand? Oh gosh. I just 10:53 you use the magic wand? Oh gosh. I just 10:53 you use the magic wand? Oh gosh. I just wish we were all incentivized for like 10:54 wish we were all incentivized for like 10:55 wish we were all incentivized for like just rather than like a two-year 10:56 just rather than like a two-year 10:56 just rather than like a two-year horizon, maybe a five-year horizon. 10:58 horizon, maybe a five-year horizon. 10:58 horizon, maybe a five-year horizon. Would that be okay? 11:00 Would that be okay? 11:00 Would that be okay? >> [laughter] 11:00 >> [laughter] 11:00 >> [laughter] >> Can we just, you know, optimize for 11:02 >> Can we just, you know, optimize for 11:02 >> Can we just, you know, optimize for patients' health in five years? It's so 11:03 patients' health in five years? It's so 11:03 patients' health in five years? It's so hard, right? Cuz we know these diseases 11:05 hard, right? Cuz we know these diseases 11:05 hard, right? Cuz we know these diseases take so long to address. So, I think 11:07 take so long to address. So, I think 11:07 take so long to address. So, I think that would be my way how can my wish how 11:09 that would be my way how can my wish how 11:09 that would be my way how can my wish how can we incentivize ourselves to take 11:11 can we incentivize ourselves to take 11:11 can we incentivize ourselves to take care of patients on, you know, longer 11:13 care of patients on, you know, longer 11:13 care of patients on, you know, longer term. And I'm just going to have one one 11:15 term. And I'm just going to have one one 11:15 term. And I'm just going to have one one wish. 11:16 wish. 11:16 wish. >> [laughter] 11:17 >> [laughter] 11:17 >> [laughter] >> I got to come back after I make my wish. 11:20 >> I got to come back after I make my wish. 11:20 >> I got to come back after I make my wish. Yeah, I think that's the principle of 11:22 Yeah, I think that's the principle of 11:22 Yeah, I think that's the principle of like the old school doc way of someone 11:24 like the old school doc way of someone 11:24 like the old school doc way of someone who take care you, your family from 11:26 who take care you, your family from 11:26 who take care you, your family from pediatric all the way to senior years. 11:29 pediatric all the way to senior years. 11:29 pediatric all the way to senior years. And then now we're seeing so 11:30 And then now we're seeing so 11:30 And then now we're seeing so fractionalized. Even you go to the same 11:32 fractionalized. Even you go to the same 11:32 fractionalized. Even you go to the same practice, you might be seeing multiple 11:34 practice, you might be seeing multiple 11:34 practice, you might be seeing multiple different providers. So, people feel 11:35 different providers. So, people feel 11:35 different providers. So, people feel like, "Oh, you have no idea what 11:38 like, "Oh, you have no idea what 11:38 like, "Oh, you have no idea what happened to me last time. You're barely 11:39 happened to me last time. You're barely 11:39 happened to me last time. You're barely reading my chart. There's no 11:41 reading my chart. There's no 11:41 reading my chart. There's no patient-provider relationship anymore, 11:43 patient-provider relationship anymore, 11:43 patient-provider relationship anymore, right?" So, that there's a friction that 11:45 right?" So, that there's a friction that 11:45 right?" So, that there's a friction that we have built to create lack of trust in 11:48 we have built to create lack of trust in 11:48 we have built to create lack of trust in the pathway. And then you also have the 11:51 the pathway. And then you also have the 11:51 the pathway. And then you also have the multiple layer of people just can't get 11:53 multiple layer of people just can't get 11:53 multiple layer of people just can't get care, right? Certain diseases, certain 11:55 care, right? Certain diseases, certain 11:55 care, right? Certain diseases, certain specialties, it's just not available, 11:57 specialties, it's just not available, 11:57 specialties, it's just not available, right? And then people are locked into 11:59 right? And then people are locked into 11:59 right? And then people are locked into certain state again, even there is 12:01 certain state again, even there is 12:01 certain state again, even there is available outside state and they have a 12:02 available outside state and they have a 12:02 available outside state and they have a high premium. So, the more that we have 12:04 high premium. So, the more that we have 12:04 high premium. So, the more that we have figured out from the payer side, from 12:07 figured out from the payer side, from 12:07 figured out from the payer side, from allowing the public understand the 12:10 allowing the public understand the 12:10 allowing the public understand the options, and then not to say a more 12:13 options, and then not to say a more 12:13 options, and then not to say a more option is a good option, right? Then 12:15 option is a good option, right? Then 12:15 option is a good option, right? Then it's an analysis paralysis. It also 12:17 it's an analysis paralysis. It also 12:17 it's an analysis paralysis. It also connected what you meant by the nurses, 12:20 connected what you meant by the nurses, 12:20 connected what you meant by the nurses, the care providers, all the way to the 12:22 the care providers, all the way to the 12:22 the care providers, all the way to the patients that 12:23 patients that 12:23 patients that care for them. And specialists, too. The 12:25 care for them. And specialists, too. The 12:25 care for them. And specialists, too. The number of times I've spoken to, you 12:27 number of times I've spoken to, you 12:27 number of times I've spoken to, you know, an ologist and a PCP, and they're 12:29 know, an ologist and a PCP, and they're 12:29 know, an ologist and a PCP, and they're like, "Well, who's responsible for their 12:30 like, "Well, who's responsible for their 12:30 like, "Well, who's responsible for their diabetes? I thought it was you. I 12:32 diabetes? I thought it was you. I 12:32 diabetes? I thought it was you. I thought it was you." 12:33 thought it was you." 12:33 thought it was you." People start bouncing, right? And it's 12:35 People start bouncing, right? And it's 12:35 People start bouncing, right? And it's different in different markets. Correct. 12:37 different in different markets. Correct. 12:37 different in different markets. Correct. And I think there's never going to be a 12:39 And I think there's never going to be a 12:39 And I think there's never going to be a right question. It's always a big how 12:41 right question. It's always a big how 12:41 right question. It's always a big how can we have an open enough dialogue and 12:43 can we have an open enough dialogue and 12:43 can we have an open enough dialogue and closed-loop communication, and not just 12:45 closed-loop communication, and not just 12:45 closed-loop communication, and not just chart it, "Oh, there's my plan. I'm 12:47 chart it, "Oh, there's my plan. I'm 12:47 chart it, "Oh, there's my plan. I'm hoping someone will just pick it up," 12:48 hoping someone will just pick it up," 12:49 hoping someone will just pick it up," right? How can we get back into that, 12:51 right? How can we get back into that, 12:51 right? How can we get back into that, "Oh, I can actually message, call, or a 12:54 "Oh, I can actually message, call, or a 12:54 "Oh, I can actually message, call, or a different automated way to actually 12:56 different automated way to actually 12:56 different automated way to actually trigger the care plan"? So, things are 12:59 trigger the care plan"? So, things are 12:59 trigger the care plan"? So, things are actually following up. We have CRM 13:01 actually following up. We have CRM 13:01 actually following up. We have CRM system. We have all these tools. Let's 13:03 system. We have all these tools. Let's 13:03 system. We have all these tools. Let's do it better, right? Like, it's not like 13:04 do it better, right? Like, it's not like 13:04 do it better, right? Like, it's not like back in the day that you're bumping into 13:06 back in the day that you're bumping into 13:06 back in the day that you're bumping into your clinician on the hallway be like, 13:08 your clinician on the hallway be like, 13:08 your clinician on the hallway be like, "Hey, let me psychocur- console you and 13:10 "Hey, let me psychocur- console you and 13:10 "Hey, let me psychocur- console you and before you go see that person," right? 13:12 before you go see that person," right? 13:12 before you go see that person," right? And we have all these tools. So, I think 13:14 And we have all these tools. So, I think 13:14 And we have all these tools. So, I think the more interoperability start coming 13:16 the more interoperability start coming 13:16 the more interoperability start coming into play, the more people like you guys 13:18 into play, the more people like you guys 13:18 into play, the more people like you guys that are actively, specially identifying 13:22 that are actively, specially identifying 13:22 that are actively, specially identifying these subgroups, will have more 13:24 these subgroups, will have more 13:24 these subgroups, will have more solutions. And it's exciting to be in 13:26 solutions. And it's exciting to be in 13:26 solutions. And it's exciting to be in this space right now. We have a lot of 13:28 this space right now. We have a lot of 13:28 this space right now. We have a lot of hope. Now it's just like, "Okay, there's
Closing Takeaways and Founder Lessons 13:30 hope. Now it's just like, "Okay, there's 13:30 hope. Now it's just like, "Okay, there's a lot of ideas. Who are the strategists 13:32 a lot of ideas. Who are the strategists 13:32 a lot of ideas. Who are the strategists to help us find that? Who are the next 13:34 to help us find that? Who are the next 13:35 to help us find that? Who are the next level of people who actually implement 13:36 level of people who actually implement 13:36 level of people who actually implement that? And then who are the true 13:38 that? And then who are the true 13:38 that? And then who are the true champions to help us talk more about 13:40 champions to help us talk more about 13:40 champions to help us talk more about these things so we can get them educated 13:42 these things so we can get them educated 13:42 these things so we can get them educated to all of that in the proper way, 13:44 to all of that in the proper way, 13:44 to all of that in the proper way, right?" I think that's so true. You have 13:46 right?" I think that's so true. You have 13:46 right?" I think that's so true. You have fancy tools, but at the end of the day 13:47 fancy tools, but at the end of the day 13:47 fancy tools, but at the end of the day it's people thinking about patients, 13:49 it's people thinking about patients, 13:49 it's people thinking about patients, working with one another, trying to 13:51 working with one another, trying to 13:51 working with one another, trying to solve problems. And that's the hardest 13:52 solve problems. And that's the hardest 13:52 solve problems. And that's the hardest part. The technology is actually easy. 13:54 part. The technology is actually easy. 13:54 part. The technology is actually easy. >> [laughter] 13:55 >> [laughter] 13:55 >> [laughter] >> So, as you guys are expanding, are you 13:56 >> So, as you guys are expanding, are you 13:56 >> So, as you guys are expanding, are you hoping to continue to expand to the 13:59 hoping to continue to expand to the 13:59 hoping to continue to expand to the payer market, more on the lung cancer 14:01 payer market, more on the lung cancer 14:01 payer market, more on the lung cancer detection side, or you guys are starting 14:03 detection side, or you guys are starting 14:03 detection side, or you guys are starting to already going down other pathways? 14:05 to already going down other pathways? 14:05 to already going down other pathways? So, like I said, we work with a lot of 14:07 So, like I said, we work with a lot of 14:07 So, like I said, we work with a lot of health plans. What we found is that it's 14:09 health plans. What we found is that it's 14:09 health plans. What we found is that it's [laughter] interesting. Medicare 14:10 [laughter] interesting. Medicare 14:10 [laughter] interesting. Medicare Advantage has actually, you know, gone a 14:12 Advantage has actually, you know, gone a 14:12 Advantage has actually, you know, gone a lot further in terms of value-based care 14:14 lot further in terms of value-based care 14:14 lot further in terms of value-based care than I think the commercial and 14:15 than I think the commercial and 14:15 than I think the commercial and self-funded market. And so, 14:16 self-funded market. And so, 14:16 self-funded market. And so, now we're starting to work a little bit 14:18 now we're starting to work a little bit 14:18 now we're starting to work a little bit more with employers, brokers, to help 14:20 more with employers, brokers, to help 14:20 more with employers, brokers, to help out the self-funded space because a lot 14:22 out the self-funded space because a lot 14:22 out the self-funded space because a lot of times, because they've taken on that 14:24 of times, because they've taken on that 14:24 of times, because they've taken on that additional risk, their provider 14:26 additional risk, their provider 14:26 additional risk, their provider ecosystem in terms of their TPAs, in 14:29 ecosystem in terms of their TPAs, in 14:29 ecosystem in terms of their TPAs, in terms of all of the different, you know, 14:30 terms of all of the different, you know, 14:30 terms of all of the different, you know, building blocks they're bringing 14:31 building blocks they're bringing 14:31 building blocks they're bringing together to make that health plan, 14:32 together to make that health plan, 14:32 together to make that health plan, they're so fragmented that it's actually 14:34 they're so fragmented that it's actually 14:34 they're so fragmented that it's actually a lot harder to do a lot of that 14:35 a lot harder to do a lot of that 14:35 a lot harder to do a lot of that value-based care. So, it's an 14:37 value-based care. So, it's an 14:37 value-based care. So, it's an interesting opportunity, and I think 14:38 interesting opportunity, and I think 14:38 interesting opportunity, and I think employers are actually the ones who are 14:40 employers are actually the ones who are 14:40 employers are actually the ones who are incentivized for a longer term wellness 14:43 incentivized for a longer term wellness 14:43 incentivized for a longer term wellness of their employees. And I'm really 14:44 of their employees. And I'm really 14:44 of their employees. And I'm really excited about that. Yeah, and now I I 14:46 excited about that. Yeah, and now I I 14:46 excited about that. Yeah, and now I I actually recently met someone who 14:48 actually recently met someone who 14:48 actually recently met someone who specialize in tax deduction for the 14:50 specialize in tax deduction for the 14:50 specialize in tax deduction for the employers. So, then they can have the 14:52 employers. So, then they can have the 14:52 employers. So, then they can have the money to use for a health plan 14:54 money to use for a health plan 14:54 money to use for a health plan incentive. I'm like, "Wow, more people 14:56 incentive. I'm like, "Wow, more people 14:56 incentive. I'm like, "Wow, more people should know about that." Because a lot 14:57 should know about that." Because a lot 14:57 should know about that." Because a lot of the question is going to be like, 14:59 of the question is going to be like, 14:59 of the question is going to be like, "How do we squeeze in? We understand 15:01 "How do we squeeze in? We understand 15:01 "How do we squeeze in? We understand retention is valuable, keeping your 15:03 retention is valuable, keeping your 15:03 retention is valuable, keeping your employee happy, right, healthy is good, 15:05 employee happy, right, healthy is good, 15:05 employee happy, right, healthy is good, but where is the allocation of fund 15:07 but where is the allocation of fund 15:07 but where is the allocation of fund coming from?" So, I think that more 15:09 coming from?" So, I think that more 15:09 coming from?" So, I think that more people can merge together for these 15:10 people can merge together for these 15:10 people can merge together for these resources, then we can really do 15:12 resources, then we can really do 15:12 resources, then we can really do something a lot bigger and then in all 15:15 something a lot bigger and then in all 15:15 something a lot bigger and then in all different facets of the support. So, I 15:17 different facets of the support. So, I 15:17 different facets of the support. So, I thank you so much for being here 15:19 thank you so much for being here 15:19 thank you so much for being here chatting. I think it's exciting for 15:21 chatting. I think it's exciting for 15:21 chatting. I think it's exciting for everything that you guys have already 15:23 everything that you guys have already 15:23 everything that you guys have already built and then can't wait to have more 15:25 built and then can't wait to have more 15:25 built and then can't wait to have more follow through to see how you guys are 15:27 follow through to see how you guys are 15:27 follow through to see how you guys are planning on next year. How can people 15:29 planning on next year. How can people 15:29 planning on next year. How can people best to continue this conversation with 15:30 best to continue this conversation with 15:30 best to continue this conversation with you? So, I love for people to read our 15:33 you? So, I love for people to read our 15:33 you? So, I love for people to read our lab trend report. That gives all the 15:35 lab trend report. That gives all the 15:35 lab trend report. That gives all the nuggets and information and insights 15:36 nuggets and information and insights 15:36 nuggets and information and insights that you need to know to get smarter on 15:38 that you need to know to get smarter on 15:38 that you need to know to get smarter on labs and diagnostics, where the 15:39 labs and diagnostics, where the 15:39 labs and diagnostics, where the different costs are in terms of site of 15:41 different costs are in terms of site of 15:41 different costs are in terms of site of care, where it's growing, what's not. 15:43 care, where it's growing, what's not. 15:43 care, where it's growing, what's not. So, Avalon Healthcare Solutions or lab 15:46 So, Avalon Healthcare Solutions or lab 15:46 So, Avalon Healthcare Solutions or lab trend reports are a great place to learn 15:47 trend reports are a great place to learn 15:47 trend reports are a great place to learn more. 15:49 more. 15:49 more. >> [music] 15:49 >> [music] 15:49 >> [music] >> What stood out to me in our last segment 15:52 >> What stood out to me in our last segment 15:52 >> What stood out to me in our last segment is that healthcare is not just about 15:54 is that healthcare is not just about 15:54 is that healthcare is not just about more options. [music] Actually, we have 15:57 more options. [music] Actually, we have 15:57 more options. [music] Actually, we have paralysis analysis and biases with 16:01 paralysis analysis and biases with 16:01 paralysis analysis and biases with choices, but rather the right options 16:04 choices, but rather the right options 16:04 choices, but rather the right options [music] for the right people at the 16:05 [music] for the right people at the 16:05 [music] for the right people at the right time. Dr. Julie also remind us 16:08 right time. Dr. Julie also remind us 16:09 right time. Dr. Julie also remind us that short-term [music] incentives often 16:11 that short-term [music] incentives often 16:11 that short-term [music] incentives often block long-term outcome. And founders, 16:15 block long-term outcome. And founders, 16:15 block long-term outcome. And founders, you need to listen closely. [music] 16:16 you need to listen closely. [music] 16:16 you need to listen closely. [music] Technology is rarely the hardest part, 16:20 Technology is rarely the hardest part, 16:20 Technology is rarely the hardest part, even though you guys tend [music] to put 16:22 even though you guys tend [music] to put 16:22 even though you guys tend [music] to put more money, more time just to improve 16:25 more money, more time just to improve 16:25 more money, more time just to improve the technology [music] itself. What you 16:27 the technology [music] itself. What you 16:27 the technology [music] itself. What you have to focus on is alignment, trust, 16:30 have to focus on is alignment, trust, 16:30 have to focus on is alignment, trust, ownership, and communication. Those are 16:33 ownership, and communication. Those are 16:34 ownership, and communication. Those are truly what will make progresses happen. 16:37 truly what will make progresses happen. 16:37 truly what will make progresses happen. Build for human first, then let the 16:40 Build for human first, then let the 16:40 Build for human first, then let the tools support your mission. Now, if you 16:43 tools support your mission. Now, if you 16:43 tools support your mission. Now, if you are a founder, [music] 16:45 are a founder, [music] 16:45 are a founder, [music] someone who has idea hasn't yet tested 16:49 someone who has idea hasn't yet tested 16:49 someone who has idea hasn't yet tested or you're already building toward those 16:51 or you're already building toward those 16:51 or you're already building toward those goals, we would love [music] to hear you 16:53 goals, we would love [music] to hear you 16:54 goals, we would love [music] to hear you at our next pitch tick yes diagnostic 16:57 at our next pitch tick yes diagnostic 16:57 at our next pitch tick yes diagnostic lab, where we have mix of founders, 17:00 lab, where we have mix of founders, 17:00 lab, where we have mix of founders, investors, [music] 17:01 investors, [music] 17:01 investors, [music] and operators listening to your ideas 17:04 and operators listening to your ideas 17:04 and operators listening to your ideas because you likely [music] wouldn't want 17:07 because you likely [music] wouldn't want 17:07 because you likely [music] wouldn't want to put a lot of time and energy and 17:09 to put a lot of time and energy and 17:09 to put a lot of time and energy and resources into something that is really 17:11 resources into something that is really 17:11 resources into something that is really needed a messaging position versus 17:14 needed a messaging position versus 17:14 needed a messaging position versus [music] something that we don't see 17:17 [music] something that we don't see 17:17 [music] something that we don't see being practical. So, before you waste 17:20 being practical. So, before you waste 17:20 being practical. So, before you waste [music] your time building all that or 17:22 [music] your time building all that or 17:22 [music] your time building all that or you are ready to fund raise, then 17:24 you are ready to fund raise, then 17:24 you are ready to fund raise, then [music] we would love to hear from your 17:26 [music] we would love to hear from your 17:26 [music] we would love to hear from your ideas and share with the rest of our 17:29 ideas and share with the rest of our 17:29 ideas and share with the rest of our ecosystem. [music] 17:30 ecosystem. [music] 17:30 ecosystem. [music] Go to pitchtoyes.com 17:33 Go to pitchtoyes.com 17:33 Go to pitchtoyes.com to apply for our next [music] 17:35 to apply for our next [music] 17:35 to apply for our next [music] diagnostic lab. 17:37 diagnostic lab. 17:37 diagnostic lab. Perfect. So, for anybody else who's 17:39 Perfect. So, for anybody else who's 17:39 Perfect. So, for anybody else who's watching, who's listening, if you're 17:41 watching, who's listening, if you're 17:41 watching, who's listening, if you're already in the diagnostic space, we 17:43 already in the diagnostic space, we 17:43 already in the diagnostic space, we would love to hear what are the 17:44 would love to hear what are the 17:44 would love to hear what are the somethings that you guys have built to 17:46 somethings that you guys have built to 17:46 somethings that you guys have built to speed up the path to being identified. 17:50 speed up the path to being identified. 17:50 speed up the path to being identified. Because at the end of the day, the 17:51 Because at the end of the day, the 17:51 Because at the end of the day, the faster we can get to a result, the 17:53 faster we can get to a result, the 17:53 faster we can get to a result, the faster we can catch up for the next 17:55 faster we can catch up for the next 17:55 faster we can catch up for the next phase of treatment and the options that 17:57 phase of treatment and the options that 17:57 phase of treatment and the options that can be discussed. And for anybody who 18:00 can be discussed. And for anybody who 18:00 can be discussed. And for anybody who really want to look into those data, go 18:02 really want to look into those data, go 18:02 really want to look into those data, go to applog and start reading those 18:04 to applog and start reading those 18:04 to applog and start reading those reports and reach out to Dr. Chung and 18:07 reports and reach out to Dr. Chung and 18:07 reports and reach out to Dr. Chung and to have those open dialogue. Many of us 18:09 to have those open dialogue. Many of us 18:09 to have those open dialogue. Many of us are very active on LinkedIn, so we can't 18:12 are very active on LinkedIn, so we can't 18:12 are very active on LinkedIn, so we can't wait to see what you guys are all ready 18:14 wait to see what you guys are all ready 18:15 wait to see what you guys are all ready being doing out there, so the more 18:16 being doing out there, so the more 18:16 being doing out there, so the more collaboration can be happening. Awesome. 18:23 Today's conversation unpacked one of the 18:23 Today's conversation unpacked one of the biggest challenges [music] in health 18:25 biggest challenges [music] in health 18:25 biggest challenges [music] in health tech scaling, which is turning 18:27 tech scaling, which is turning 18:27 tech scaling, which is turning diagnostics and clinical data [music] 18:29 diagnostics and clinical data [music] 18:30 diagnostics and clinical data [music] into faster, actionable treatment 18:32 into faster, actionable treatment 18:32 into faster, actionable treatment decisions inside real health care 18:34 decisions inside real health care 18:34 decisions inside real health care workflows. We explored how payer 18:36 workflows. We explored how payer 18:36 workflows. We explored how payer partnerships, prior authorization 18:38 partnerships, prior authorization 18:38 partnerships, prior authorization [music] strategy, precision medicine, 18:41 [music] strategy, precision medicine, 18:41 [music] strategy, precision medicine, and workflow design directly impact 18:43 and workflow design directly impact 18:43 and workflow design directly impact adoption, care coordination, [music] 18:46 adoption, care coordination, [music] 18:46 adoption, care coordination, [music] and health care waste. And for founders 18:48 and health care waste. And for founders 18:48 and health care waste. And for founders building in diagnostics, AI decision 18:51 building in diagnostics, AI decision 18:51 building in diagnostics, AI decision [music] support, oncology technology, or 18:53 [music] support, oncology technology, or 18:53 [music] support, oncology technology, or value-based care with payer innovation, 18:56 value-based care with payer innovation, 18:56 value-based care with payer innovation, [music] 18:57 [music] 18:57 [music] this is the real work behind creating 18:59 this is the real work behind creating 18:59 this is the real work behind creating scalable health care outcomes. Here are 19:02 scalable health care outcomes. Here are 19:02 scalable health care outcomes. Here are the key learning points [music] 19:05 the key learning points [music] 19:05 the key learning points [music] from today's interview. Number one, if 19:07 from today's interview. Number one, if 19:08 from today's interview. Number one, if clinicians must work harder to use your 19:10 clinicians must work harder to use your 19:10 clinicians must work harder to use your product, adoption [music] will stall. 19:12 product, adoption [music] will stall. 19:12 product, adoption [music] will stall. Even strong science loses when workflow 19:15 Even strong science loses when workflow 19:15 Even strong science loses when workflow gets messy. If your solution adds 19:18 gets messy. If your solution adds 19:18 gets messy. If your solution adds clicks, extra logins, or more tasks, 19:21 clicks, extra logins, or more tasks, 19:21 clicks, extra logins, or more tasks, busy clinicians will avoid it. The best 19:24 busy clinicians will avoid it. The best 19:24 busy clinicians will avoid it. The best product [music] fits smoothly into 19:27 product [music] fits smoothly into 19:27 product [music] fits smoothly into existing workflows and save time 19:29 existing workflows and save time 19:29 existing workflows and save time immediately. 19:30 immediately. 19:30 immediately. >> [music] 19:30 >> [music] 19:30 >> [music] >> Number two, buyers don't purchase 19:32 >> Number two, buyers don't purchase 19:32 >> Number two, buyers don't purchase innovation. They purchase fewer [music] 19:35 innovation. They purchase fewer [music] 19:35 innovation. They purchase fewer [music] headaches. 19:36 headaches. 19:36 headaches. Founders often sell features, but buyers 19:39 Founders often sell features, but buyers 19:39 Founders often sell features, but buyers want relief. If your product reduces 19:42 want relief. If your product reduces 19:42 want relief. If your product reduces admin burden, [music] prior off 19:44 admin burden, [music] prior off 19:45 admin burden, [music] prior off friction, or reporting chaos, it becomes 19:48 friction, or reporting chaos, it becomes 19:48 friction, or reporting chaos, it becomes valuable fast. 19:50 valuable fast. 19:50 valuable fast. In healthcare, simplicity [music] often 19:52 In healthcare, simplicity [music] often 19:52 In healthcare, simplicity [music] often wins over novelty. 19:55 wins over novelty. 19:55 wins over novelty. Number three, your best [music] ROI 19:57 Number three, your best [music] ROI 19:57 Number three, your best [music] ROI metric might be speed. Reducing 20:00 metric might be speed. Reducing 20:00 metric might be speed. Reducing treatment delays creates both financial 20:02 treatment delays creates both financial 20:02 treatment delays creates both financial [music] 20:03 [music] 20:03 [music] and clinical value. 20:05 and clinical value. 20:05 and clinical value. Faster diagnosis, approval, and therapy 20:08 Faster diagnosis, approval, and therapy 20:08 Faster diagnosis, approval, and therapy access [music] can improve outcomes 20:10 access [music] can improve outcomes 20:10 access [music] can improve outcomes while lowering avoidable costs. 20:13 while lowering avoidable costs. 20:13 while lowering avoidable costs. Speed is [music] a metric buyers 20:16 Speed is [music] a metric buyers 20:16 Speed is [music] a metric buyers understand instantly. 20:18 understand instantly. 20:18 understand instantly. Number four, incentives [music] shape 20:20 Number four, incentives [music] shape 20:20 Number four, incentives [music] shape behavior more than 20:22 behavior more than 20:22 behavior more than intentions do. Most stakeholders want 20:26 intentions do. Most stakeholders want 20:26 intentions do. Most stakeholders want better care, but [music] they still 20:28 better care, but [music] they still 20:28 better care, but [music] they still follow budgets, reimbursement models, 20:31 follow budgets, reimbursement models, 20:31 follow budgets, reimbursement models, and performance [music] targets. 20:33 and performance [music] targets. 20:33 and performance [music] targets. If the system rewards short-term 20:35 If the system rewards short-term 20:36 If the system rewards short-term decisions, behavior will follow. 20:38 decisions, behavior will follow. 20:39 decisions, behavior will follow. Founders must sell into reality, not 20:41 Founders must sell into reality, not 20:41 Founders must sell into reality, not theory. [music] 20:42 theory. [music] 20:42 theory. [music] Number five, big opportunities live 20:45 Number five, big opportunities live 20:45 Number five, big opportunities live inside fragmented system. Healthcare 20:48 inside fragmented system. Healthcare 20:48 inside fragmented system. Healthcare gaps often [music] exist because payers, 20:51 gaps often [music] exist because payers, 20:51 gaps often [music] exist because payers, providers, specialists, and patients all 20:54 providers, specialists, and patients all 20:54 providers, specialists, and patients all have to coexist [music] together. When 20:56 have to coexist [music] together. When 20:56 have to coexist [music] together. When no one clearly owns the problem, 21:00 no one clearly owns the problem, 21:00 no one clearly owns the problem, progress stalls. [music] 21:01 progress stalls. [music] 21:01 progress stalls. [music] Founders who create coordination and 21:04 Founders who create coordination and 21:04 Founders who create coordination and clarity can unlock major value. Number 21:07 clarity can unlock major value. Number 21:07 clarity can unlock major value. Number six, [music] fancy tools don't fix 21:10 six, [music] fancy tools don't fix 21:10 six, [music] fancy tools don't fix broken communication. Technology helps, 21:13 broken communication. Technology helps, 21:13 broken communication. Technology helps, but trust and accountability still 21:15 but trust and accountability still 21:15 but trust and accountability still drives results. Many delays happen 21:18 drives results. Many delays happen 21:18 drives results. Many delays happen because teams are misaligned [music] 21:21 because teams are misaligned [music] 21:21 because teams are misaligned [music] or no one closes the loop. In 21:25 or no one closes the loop. In 21:25 or no one closes the loop. In healthcare, people determine whether 21:27 healthcare, people determine whether 21:27 healthcare, people determine whether innovation succeeds. 21:30 innovation succeeds. 21:30 innovation succeeds. Now, let me ask you this. If your buck 21:32 Now, let me ask you this. If your buck 21:32 Now, let me ask you this. If your buck ears only think six to traumas ahead, 21:36 ears only think six to traumas ahead, 21:36 ears only think six to traumas ahead, how are you selling a five-year [music] 21:38 how are you selling a five-year [music] 21:38 how are you selling a five-year [music] outcome? 21:40 outcome? 21:40 outcome? Thank you for listening. Remember, the 21:42 Thank you for listening. Remember, the 21:42 Thank you for listening. Remember, the positive change we're seeking [music] 21:44 positive change we're seeking [music] 21:44 positive change we're seeking [music] starts right here with me and you. If 21:47 starts right here with me and you. If 21:47 starts right here with me and you. If you are a fan of the show or [music] if 21:49 you are a fan of the show or [music] if 21:49 you are a fan of the show or [music] if you are just having struggles or success 21:53 you are just having struggles or success 21:53 you are just having struggles or success that you're either experienced in the 21:55 that you're either experienced in the 21:55 that you're either experienced in the past or are experiencing now in the 21:58 past or are experiencing now in the 21:58 past or are experiencing now in the healthcare [music] industry, these 22:00 healthcare [music] industry, these 22:00 healthcare [music] industry, these matter to all of us. I want to hear from 22:03 matter to all of us. I want to hear from 22:03 matter to all of us. I want to hear from you. Visit sabrinarombach.com/connect 22:07 you. Visit sabrinarombach.com/connect 22:07 you. Visit sabrinarombach.com/connect >> [music]
Comments